Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Dunstan, CR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 47 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bolon, B; Carter, C; Daris, M; Morony, S; Capparelli, C; Hsieh, A; Mao, MF; Kostenuik, P; Dunstan, CR; Lacey, DL; Sheng, JZ
      Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis

      MOLECULAR THERAPY
    2. Brown, JM; Vessella, RL; Kostenuik, PJ; Dunstan, CR; Lange, PH; Corey, E
      Serum osteoprotegerin levels are increased in patients with advanced prostate cancer

      CLINICAL CANCER RESEARCH
    3. Ross, AB; Bateman, TA; Kostenuik, PJ; Ferguson, VL; Lacey, DL; Dunstan, CR; Simske, SJ
      The effects of osteoprotegerin on the mechanical properties of rat bone

      JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
    4. Bekker, PJ; Holloway, D; Nakanishi, A; Arrighi, M; Leese, PT; Dunstan, CR
      The effect of a single dose of osteoprotegerin in postmenopausal women

      JOURNAL OF BONE AND MINERAL RESEARCH
    5. Bateman, TA; Dunstan, CR; Lacey, DL; Ferguson, VL; Ayers, RA; Simske, SJ
      Osteoprotegerin ameliorates sciatic nerve crush induced bone loss

      JOURNAL OF ORTHOPAEDIC RESEARCH
    6. Kostenuik, PJ; Capparelli, C; Morony, S; Adamu, S; Shimamoto, G; Shen, V; Lacey, DL; Dunstan, CR
      OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats

      ENDOCRINOLOGY
    7. Morony, S; Capparelli, C; Sarosi, I; Lacey, DL; Dunstan, CR; Kostenuik, PJ
      Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden insyngeneic and nude mouse models of experimental bone metastasis

      CANCER RESEARCH
    8. Croucher, PI; Shipman, CM; Lippitt, J; Perry, M; Asosingh, K; Hijzen, A; Brabbs, AC; van Beek, EJR; Holen, I; Skerry, TM; Dunstan, CR; Russell, GR; Van Camp, B; Vanderkerken, K
      Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma

      BLOOD
    9. Hofbauer, LC; Shui, CX; Riggs, BL; Dunstan, CR; Spelsberg, TC; O'Brien, T; Khosla, S
      Effects of immunosuppressants on receptor activator of NF-kappa B ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    10. Bateman, TA; Dunstan, CR; Ferguson, VL; Lacey, DL; Ayers, RA; Simske, SJ
      Osteoprotegerin mitigates tail suspension-induced osteopenia

      BONE
    11. Dunstan, CR
      Osteoprotegerin and osteoprotegerin ligand mediate the local regulation ofbone resorption

      ENDOCRINOLOGIST
    12. Hofbauer, LC; Khosla, S; Dunstan, CR; Lacey, DL; Boyle, WJ; Riggs, BL
      The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption

      JOURNAL OF BONE AND MINERAL RESEARCH
    13. Li, J; Sarosi, I; Yan, XQ; Morony, S; Capparelli, C; Tan, HL; McCabe, S; Elliott, R; Scully, S; Van, G; Kaufman, S; Juan, SC; Sun, Y; Tarpley, J; Martin, L; Christensen, K; McCabe, J; Kostenuik, P; Hsu, H; Fletcher, F; Dunstan, CR; Lacey, DL; Boyle, WJ
      RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    14. Min, H; Morony, S; Sarosi, I; Dunstan, CR; Capparelli, C; Scully, S; Van, G; Kaufman, S; Kostenuik, PJ; Lacey, DL; Boyle, TJ; Simonet, WS
      Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

      JOURNAL OF EXPERIMENTAL MEDICINE
    15. Gori, F; Hofbauer, LC; Dunstan, CR; Spelsberg, TC; Khosla, S; Riggs, BL
      The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated

      ENDOCRINOLOGY
    16. Capparelli, C; Kostenuik, PJ; Morony, S; Starnes, C; Weimann, B; Van, G; Scully, S; Qi, MY; Lacey, DL; Dunstan, CR
      Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy

      CANCER RESEARCH
    17. Hofbauer, LC; Lacey, DL; Dunstan, CR; Spelsberg, TC; Riggs, BL; Khosla, S
      Interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6,stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

      BONE
    18. Lomaga, MA; Yeh, WC; Sarosi, I; Duncan, GS; Furlonger, C; Ho, A; Morony, S; Capparelli, C; Van, G; Kaufman, S; van der Heiden, A; Itie, A; Wakeham, A; Khoo, W; Sasaki, T; Cao, ZD; Penninger, JM; Paige, CJ; Lacey, DL; Dunstan, CR; Boyle, WJ; Goeddel, DV; Mak, TW
      TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

      GENES & DEVELOPMENT
    19. Morony, S; Capparelli, C; Lee, R; Shimamoto, G; Boone, T; Lacey, DL; Dunstan, CR
      A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1 beta, TNF-alpha, PTH, PTHrP, and 1,25(OH)(2)D-3

      JOURNAL OF BONE AND MINERAL RESEARCH
    20. Dunstan, CR; Boyce, R; Boyce, BF; Garrett, IR; Izbicka, E; Burgess, WH; Mundy, GR
      Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats

      JOURNAL OF BONE AND MINERAL RESEARCH
    21. Shalhoub, V; Faust, J; Boyle, WJ; Dunstan, CR; Kelley, M; Kaufman, S; Scully, S; Van, G; Lacey, DL
      Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formationfrom human peripheral blood mononuclear cell precursors

      JOURNAL OF CELLULAR BIOCHEMISTRY
    22. Kong, YY; Yoshida, H; Sarosi, I; Tan, HL; Timms, E; Capparelli, C; Morony, S; Oliveira-dos-Santos, AJ; Van, G; Itie, A; Khoo, W; Wakeham, A; Dunstan, CR; Lacey, DL; Mak, TW; Boyle, WJ; Penninger, JM
      OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

      NATURE
    23. Hsu, HL; Lacey, DL; Dunstan, CR; Solovyev, I; Colombero, A; Timms, E; Tan, HL; Elliott, G; Kelley, MJ; Sarosi, I; Wang, L; Xia, XZ; Elliott, R; Chiu, L; Black, T; Scully, S; Capparelli, C; Morony, S; Shimamoto, G; Bass, MB; Boyle, WJ
      Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    24. Burgess, TL; Qian, YX; Kaufman, S; Ring, BD; Van, G; Capparelli, C; Kelley, M; Hsu, HL; Boyle, WJ; Dunstan, CR; Hu, S; Lacey, DL
      The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts

      JOURNAL OF CELL BIOLOGY
    25. Hofbauer, LC; Khosla, S; Dunstan, CR; Lacey, DL; Spelsberg, TC; Riggs, BL
      Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells

      ENDOCRINOLOGY
    26. Hofbauer, LC; Gori, F; Riggs, BL; Lacey, DL; Dunstan, CR; Spelsberg, TC; Khosla, S
      Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis

      ENDOCRINOLOGY
    27. BOYLE WJ; HSU HL; PENNINGER J; DUNSTAN CR; SIMONET WS; LACEY DL
      REGULATION OF BONE-DENSITY VIA THE OPG, OPGL (RANKL), AND ODAR (RANK)TRIANGLE

      European cytokine network
    28. BUCAY N; SAROSI I; DUNSTAN CR; MORONY S; TARPLEY J; CAPPARELLI C; SCULLY S; TAN HL; XU WL; LACEY DL; BOYLE WJ; SIMONET WS
      OSTEOPROTEGERIN-DEFICIENT MICE DEVELOP EARLY-ONSET OSTEOPOROSIS AND ARTERIAL CALCIFICATION

      Genes & development
    29. LACEY DL; TIMMS E; TAN HL; KELLEY MJ; DUNSTAN CR; BURGESS T; ELLIOTT R; COLOMBERO A; ELLIOTT G; SCULLY S; HSU H; SULLIVAN J; HAWKINS N; DAVY E; CAPPARELLI C; ELI A; QIAN YX; KAUFMAN S; SAROSI I; SHALHOUB V; SENALDI G; GUO J; DELANEY J; BOYLE WJ
      OSTEOPROTEGERIN LIGAND IS A CYTOKINE THAT REGULATES OSTEOCLAST DIFFERENTIATION AND ACTIVATION

      Cell
    30. ZUBERY Y; DUNSTAN CR; STORY BM; KESAVALU L; EBERSOLE JL; HOLT SC; BOYCE BF
      BONE-RESORPTION CAUSED BY 3 PERIODONTAL PATHOGENS IN-VIVO IN MICE IS MEDIATED IN PART BY PROSTAGLANDIN

      Infection and immunity
    31. HOFBAUER LC; DUNSTAN CR; SPELSBERG TC; RIGGS BL; KHOSLA S
      OSTEOPROTEGERIN PRODUCTION BY HUMAN OSTEOBLAST LINEAGE CELLS IS STIMULATED BY VITAMIN-D, BONE MORPHOGENETIC PROTEIN-2, AND CYTOKINES

      Biochemical and biophysical research communications (Print)
    32. DUNSTAN CR; CAPPARELLI C; KELLEY M; SHIMAMOTO G; KAUFMAN S; RUSSELL D; CAMPAGNUOLO G; STARNES C; WIEMAN B; LACEY D
      OSTEOPROTEGERIN (OPG), A NOVEL TNF-RECEPTOR FAMILY MEMBER PROFOUNDLY INHIBITS ENDOSTEAL BONE-RESORPTION DUE TO GROWTH, HUMORAL HYPERCALCEMIA OF MALIGNANCY, AND INTERLEUKIN-1

      Journal of bone and mineral research
    33. CHEN D; HARRIS MA; ROSSINI G; DUNSTAN CR; DALLAS SL; FENG JQ; MUNDY GR; HARRIS SE
      BONE MORPHOGENETIC PROTEIN-2 (BMP-2) ENHANCES BMP-3, BMP-4, AND BONE CELL-DIFFERENTIATION MARKER GENE-EXPRESSION DURING THE INDUCTION OF MINERALIZED BONE-MATRIX FORMATION IN CULTURES OF FETAL-RAT CALVARIAL OSTEOBLASTS

      Calcified tissue international
    34. IZBICKA E; DUNSTAN CR; HORN D; ADAMS R; MUNDY GR
      MITOGENIC LECTIN CONCANAVALIN-A INDUCES CALVARIAL BONE-FORMATION IN-VIVO VIA INDOMETHACIN-SENSITIVE PATH NAY

      Calcified tissue international
    35. IZBICKA E; DUNSTAN CR; HORN D; HARRIS M; HARRIS S; ADAMS R; MUNDY GR
      EFFECTS OF HUMAN TUMOR-CELL LINES ON LOCAL NEW BONE-FORMATION IN-VIVO

      Calcified tissue international
    36. SIMONET WS; LACEY DL; DUNSTAN CR; KELLEY M; CHANG MS; LUTHY R; NGUYEN HQ; WOODEN S; BENNETT L; BOONE T; SHIMAMOTO G; DEROSE M; ELLIOTT R; COLOMBERO A; TAN HL; TRAIL G; SULLIVAN J; DAVY E; BUCAY N; RENSHAWGEGG L; HUGHES TM; HILL D; PATTISON W; CAMPBELL P; SANDER S; VAN G; TARPLEY J; DERBY P; LEE R; BOYLE WJ
      OSTEOPROTEGERIN - A NOVEL SECRETED PROTEIN INVOLVED IN THE REGULATIONOF BONE-DENSITY

      Cell
    37. UY HL; MUNDY GR; BOYCE BF; STORY BM; DUNSTAN CR; YIN JJ; ROODMAN GD; GUISE TA
      TUMOR-NECROSIS-FACTOR ENHANCES PARATHYROID HORMONE-RELATED PROTEIN-INDUCED HYPERCALCEMIA AND BONE-RESORPTION WITHOUT INHIBITING BONE-FORMATION IN-VIVO

      Cancer research
    38. MBALAVIELE G; DUNSTAN CR; SASAKI A; WILLIAMS PJ; MUNDY GR; YONEDA T
      E-CADHERIN EXPRESSION IN HUMAN BREAST-CANCER CELLS SUPPRESSES THE DEVELOPMENT OF OSTEOLYTIC BONE METASTASES IN AN EXPERIMENTAL METASTASIS MODEL

      Cancer research
    39. DUNSTAN CR; GARRETT IR; ADAMS R; BURGESS W; JAYE M; YOUNGS T; BOYCE R; MUNDY GR
      SYSTEMIC FIBROBLAST GROWTH-FACTOR (FGF-1) PREVENTS BONE LOSS, INCREASES NEW BONE-FORMATION, AND RESTORES TRABECULAR MICROARCHITECTURE IN OVARIECTOMIZED RATS

      Journal of bone and mineral research
    40. CHEN D; ROSSINI G; FENG JQ; DUNSTAN CR; GHOSHCHOUDHURY N; DALLAS SJ; HARRIS MA; MUNDY GR; HARRIS SE
      EVIDENCE THAT BMP-2 ACTS AS AN AUTOCRINE PARACRINE FACTOR IN OSTEOBLAST DIFFERENTIATION

      Journal of bone and mineral research
    41. GARCIA C; DALLAS M; BOYCE BF; DUNSTAN CR; MUNDY GR; BONEWALD LF
      EVIDENCE THAT PEPTIDO-LEUKOTRIENES STIMULATE OSTEOCLASTS TO RESORB BONE IN-VITRO AND IN-VIVO

      Journal of bone and mineral research
    42. GUTIERREZ G; GALLWITZ W; GARRETT IR; ROSSINI G; DUNSTAN CR; IZBICKA E; JACOBS C; BONEWALD L; ARNETT T; BURGESS W; MUNDY GR
      IDENTIFICATION OF A NOVEL BONE-DERIVED GROWTH-REGULATORY FACTOR WHICHIS EXPRESSED IN OSTEOCLASTS

      Journal of bone and mineral research
    43. GARRETT IR; CHAVEZ J; CASTANO M; BOYCE B; DUNSTAN CR; ADAMS R; RADL J; MUNDY G
      IDENTIFICATION OF A NOVEL ANIMAL-MODEL OF OSTEOLYTIC BONE-LESIONS IN MYELOMA

      Journal of bone and mineral research
    44. GUISE TA; CHIRGWIN JM; TAYLOR S; BOYCE BF; DUNSTAN CR; MUNDY GR
      DELETIONS OF C-TERMINAL END OF PARATHYROID HORMONE-RELATED PROTEIN (PTHRP) HAVE EQUIVALENT EFFECTS ON BONE AND CALCIUM HOMEOSTASIS IN-VIVO

      Journal of bone and mineral research
    45. DUNSTAN CR; BOYCE BF; IZBICKA E; ADAMS R; MUNDY GR
      ACIDIC AND BASIC FIBROBLAST GROWTH-FACTORS PROMOTE BONE-GROWTH IN-VIVO COMPARABLE TO THAT OF TGF-BETA

      Journal of bone and mineral research
    46. WILLIAMS P; BOYCE BF; RHINE C; DUNSTAN CR; MUNDY GR; YONEDA T
      SURAMIN REDUCES CANCER-INDUCED HYPERCALCEMIA IN-VIVO AND BONE-RESORPTION IN-VITRO

      Journal of bone and mineral research
    47. DUNSTAN CR; SOMERS NM; EVANS RA; RUBIN; OTT; SNYDER; DAVY; SCHAFFLER; PARFITT; GOLDSTEIN
      OSTEOCYTE DEATH AND HIP FRACTURE

      Calcified tissue international


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 13:03:39